Back to Search
JOSE BATLLE, M.D.
M.D.
Internal Medicine Physician
NPI: 1639122575Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
212090(NY)
Research & Publications (20)
Bevacizumab: a safe and effective treatment in a patient with advanced colorectal cancer and repeated removal of metastases.
PMID 19352110·Anticancer Drugs·2009
8-other
Autosomal dominant C1149R von Willebrand disease: phenotypic findings and their implications.
PMID 19286880·Haematologica·2009
8-other
Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study.
PMID 19566550·J Thromb Haemost·2009
7-preclinical
Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD.
PMID 18230755·Blood·2008
3-trial
Consensus opinion for the selection and use of therapeutic products for the treatment of haemophilia in Spain.
PMID 18600079·Blood Coagul Fibrinolysis·2008
6-review
Cyclosporine 0.05% ophthalmic preparation to aid recovery from loss of corneal sensitivity after LASIK.
PMID 18500081·J Refract Surg·2008
2-rct
Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).
PMID 18344424·Blood·2008
4-observational
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD).
PMID 18315556·J Thromb Haemost·2008
4-observational
Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).
PMID 16985174·Blood·2007
4-observational
[Lessons about recombinant activated factor VII. Ten years since its registration for use in hemophilia complicated with inhibitor].
PMID 17915135·Med Clin (Barc)·2007
8-other
Mutational analysis of the von Willebrand factor gene in type 1 von Willebrand disease using conformation sensitive gel electrophoresis: a comparison of fluorescent and manual techniques.
PMID 17488667·Haematologica·2007
4-observational
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD).
PMID 17408405·J Thromb Haemost·2007
4-observational
[Current role of MRI for the local staging of prostate cancer].
PMID 17283713·Arch Esp Urol·2006
6-review
Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD.
PMID 16634746·J Thromb Haemost·2006
8-other
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD).
PMID 16634745·J Thromb Haemost·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 325 AUDUBON AVE
NEW YORK, NY 10033 - Phone
- (201) 456-1342
Quick Facts
- NPI
- 1639122575
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile